Advertisements
Amaewhule et al
|
Greener Journal of Medical Sciences Vol. 11(2), pp. 116-121, 2021 ISSN: 2276-7797 Copyright ©2021, the copyright of this article is retained by the author(s) |
|
Seroprevalence of Chlamydia trachomatis Antibodies and Associated Risk Factors Among HIV Positive Patients Seen in Enugu.
Amaewhule Mary Nnenda1, Bob-Manuel Mienye2, Lawson Stephenson Danagogo2
1 Department of Internal Medicine, Rivers State University Teaching Hospital.
2Department of Medical Microbiology and Parasitology, Rivers State University Teaching Hospital.
|
ARTICLE INFO |
ABSTRACT |
|
Article No.:092721094 Type: Research
|
A cross-sectional study of Chlamydia trachomatis antibody seroprevalence was carried out among persons living with HIV in Enugu, Nigeria. One hundred and fifty persons diagnosed of HIV and receiving treatment at the University of Nigeria Teaching Hospital, Enugu were recruited for the study. Enzyme-linked immunosorbent assay kits were used to assess the seroprevalence of Chlamydia trachomatis antibodies among the participants. A structured PROFORMA was used to collect data on demographic factors and high-risk behaviours. The results showed a 60.7% (91/150) of Chlamydia trachomatis antibodies among the study participants. Among the participants with antibodies, the IgM prevalence was 51.6% (47/91), while IgG was 35.2% (32/91) and both IgM and IgG were 13.2% (12/91). Logistic regression showed that the risk of chlamydia infection was increased with the history of STD (OR = 1.4, (0.7 – 2.7)), history of multiple sexual partners (OR = 1.9, (0.9 – 3.7)), those currently sexually active (OR = 1.5, (0.7 – 3.1)), the use of unsterilized objects (OR = 4.9, (2.3 – 10.4)) and the irregular or non-usage of condoms (OR = 10.2 (4.6 – 22.7)). The findings of the study showed a high prevalence of C. trachomatis antibodies among the participants. Although these may not all represent active C. trachomatis infection, it can be inferred that a high percentage of the population has been exposed to the infection and many of them may still be harbouring this infection inadvertently. This may contribute to the high rate of spread of this infection as well as HIV in Nigeria. |
|
Accepted: 27/09/2021 Published: 11/10/2021 |
|
|
*Corresponding Author Bob-Manuel Mienye E-mail: mienye.bob-manuel@ ust.edu.ng |
|
|
Keywords: Chlamydia; HIV; IgG; IgM |
|
|
|
|
Return to Content View [Full Article - PDF] |
REFERENCES
1. Budai I. Chlamydia Trachomatis: Milestones in clinical and microbiological diagnostics in the last hundred years. Acta Microbiol Immunol Hung. 2007;54(1):5–22.
2. Harris SR, Clarke IN, Seth-Smith HMB, Solomon AW, Cutcliffe LT, Marsh P, et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet. 2012;44(4):413–9.
3. Postema EJ, Remeijer L, Van Der Meijden WI. Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis; a retrospective study. Sex Transm Infect. 1996;72(3):203–5.
4. Keat AC, Thomas BJ, Taylor-Robinson D, Pegrum GD, Maini RN, Scott JT. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis. 1980;39(5):431–7.
5. Hughes RA, Keat AC. Reiter’s syndrome and reactive arthritis: a current view. Semin Arthritis Rheum. 1994;24(3):190–210.
6. Rowley J, Hoorn S Vander, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–62.
7. Huai P, Li F, Chu T, Liu D, Liu J, Zhang F. Prevalence of genital Chlamydia trachomatis infection in the general population: A meta-analysis. BMC Infect Dis. 2020;20(1):1–8.
8. Nwankwo EO, Sadiq MN. Prevalence of chlamydia trachomatis infection among patients attending infertility and sexually transmitted diseases clinic (STD) in Kano, north western Nigeria. Afr Health Sci. 2014;14(1):672–8.
9. Arinze AUH, Onyebuchi NV, Isreal J. Genital chlamydia trachomatis infection among female undergraduate students of University of Port Harcourt, Nigeria. Niger Med J. 2014 Jan;55(1):9–13.
10. Ikeme AC, Ezegwui HU, Ikeako LC, Agbata I, Agbata E. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria. Niger J Clin Pract. 2011;14(2):176–80.
11. Izebe K. S., Ngwai Y. B., Ekpeyong M., Ezeunala M., Ajoku G. A., Oladosu P., et al. Detection of anti-Chlamydia trachomatis antibodies in Patients with Acquired Immune Deficiency Syndrome in Abuja, Nigeria. Malays J Microbiol. 2008;4(1):44–8.
12. Otuonye NM, Olukoya DK, Odunukwe NN, Idigbe EO, Udeaja MN, Bamidele M, et al. HIV association with conventional STDS (sexual transmitted diseases) in Lagos State, Nigeria. West Afr J Med. 2002;21(2):153–6.
13. Brunham RC, Kimani J, Bwayo J, Maitha G, Maclean I, Yang C, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis. 1996;173(4):950–6.
14. Ghys PD, Fransen K, Diallo MO, Ettiègne-Traore V, Coulibaly IM, Yeboue KM, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire. Aids. 1997;11(12).
15. Chernesky MA. The laboratory diagnosis of Chlamydia trachomatis infections. Can J Infect Dis Med Microbiol. 2005;16(1):39–44.
16. Logan PGB and GD. 基因的改变NIH Public Access [Internet]. Vol. 23, Bone. 2014. 1–7 p. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf
17. Meyer T. Diagnostic Procedures to Detect Chlamydia trachomatis Infections. Microorganisms. 2016 Aug;4(3).
18. DIA.PRO. Chlamydia trachomatis IgG ELISA. 2015;49(0):0–8. Available from: https://www.diapro.it/index.php/products/elisa/serology/c-trachomatis/ctg-igg-detail
19. Automation D. Chlamydia Trachomatis Igm Antistoffen. Zol [Internet]. (818):1–5. Available from: https://www.zol.be/klinisch-laboratorium/labogids/analyse/chlamydia-trachomatis-igm-antistoffen%0D
20. S Takuva OMJMAMAMVMFCSMPMDL. Etiology and antimicrobial susceptibility of pathogens responsible for urethral discharge among men in Harare, Zimbabwe. Sex Transm Dis. 2014;41(12):713–7.
21. K Rebe DLLMGSHSMKJM. A cross sectional analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One. 2015 Sep 29;10(9):e0138315.
22. Mafokwane TM, Samie A. Prevalence of chlamydia among HIV positive and HIV negative patients in the Vhembe District as detected by real time PCR from urine samples. BMC Res Notes 2016 91 [Internet]. 2016 Feb 16 [cited 2021 Aug 3];9(1):1–10. Available from: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-016-1887-8
23. Adachi K, Klausner JD, Bristow CC, Xu J, Ank B, Morgado MG, et al. Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission. Sex Transm Dis. 2015 Oct 1;42(10):554–65.
24. Morhason-Bello IO. The prevalence and outcome of asymptomatic chlamydial infection screening among infertile women attending gynecological clinic in ibadan, South west Nigeria. Ann Med Heal Sci Res. 2014;4(2):253–7.
25. Horner P, Soldan K, Vieira SM, Wills GS, Woodhall SC, Pebody R, et al. C. trachomatis pgp3 Antibody Prevalence in Young Women in England, 1993–2010. PLoS One [Internet]. 2013 Aug 21 [cited 2021 Aug 3];8(8):e72001. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072001.
|
Cite this Article: Amaewhule, NM; Bob-Manuel, M; Lawson, DS (2021).Seroprevalence of Chlamydia trachomatis Antibodies and Associated Risk Factors Among HIV Positive Patients Seen in Enugu. Greener Journal of Medical Sciences, 11(2): 116-121.
|
Call for Papers
Call for Scholarly Articles
Authors from around the world are invited to send scholary articles that suits the scope of this journal. The journal is currently open to submissions and will process and publish articles monthly in two yearly issues.
The journal is centered on quality and goes about its processes in a very timely fashion. Seasoned editors/reviewers will be consulted to review each article(s), profer quality evaluations and polish the articles with expertise before publication.
Simply send your article(s) as an e-mail attachment to manuscripts@acad.gjournals.org or manuscripts.igj@gmail.com.
Advertisements
